Urinary thrombin as a non-invasive biomarker in renal diseases: a possible role in the detection of segmental sclerosis lesions in IgA nephropathy | Synapse
March 3, 2026
Urinary thrombin as a non-invasive biomarker in renal diseases: a possible role in the detection of segmental sclerosis lesions in IgA nephropathy
Puntos clave
Urinary thrombin levels are associated with segmental sclerosis in renal diseases, particularly IgA nephropathy.
Elevated urinary thrombin levels were observed in patients with segmental sclerosis lesions, pointing to its potential as a biomarker.
Observational analysis highlighted the role of urinary thrombin as a non-invasive marker for renal disease assessment.
Findings suggest a new approach for diagnosing renal conditions, potentially reducing the need for invasive biopsy procedures.